Trending...
- Red5 Taps PubNub to Power the Next Era of Real-Time Interactive Streaming
- Kettera Strategies Selects Bite Stream
- NYC Composer/Educator Launches Debut Children's Book to Fantastic Reviews
CHICAGO, Oct. 8, 2024 ~ Chicago, IL - Axtria Inc., a global leader in cloud software and data analytics for the life sciences industry, showcased its leadership in driving innovative solutions for pharmaceutical companies at the PMSA 2024 Fall Symposium. The two-day summit, held on October 3-4, 2024, brought together industry leaders, researchers, and academics to explore the transformative impact of AI in healthcare.
During the conference, Axtria received several awards for its thought leadership presentations and participated as a gold sponsor, reaffirming its commitment to exchanging knowledge and enhancing the impact of AI in the pharmaceutical industry.
Sudip Chakraborty, Principal and Head of AI/GenAI at Axtria, stated that "At Axtria, we believe that AI is not just a tool but a transformative force that can reshape the pharmaceutical landscape." He also emphasized their dedication to partnering with industry leaders to harness AI-driven insights and solutions that improve decision-making, optimize field operations, and ultimately enhance patient outcomes.
More on illi News
Axtria's experts collaborated with client partners to lead insightful presentations and discussions on advanced AI-driven solutions and strategies tailored for the pharmaceutical industry. Some of these sessions included:
- A case study presented by Axtria and Gilead Sciences on "Nuances of Leveraging Generative AI for Structured Data Processing and Insights." This highlighted the importance of empowering non-technical users to access insights through natural language generation-based applications. These GenAI-powered tools provide intuitive user interfaces with robust data access controls, enabling broader access to critical insights.
- A collaboration between Axtria and Astellas Pharma on "AI-Enabled Action Alerts to Enhance Field Effectiveness." This session demonstrated how AI-powered recommendations are transforming field operations by providing representatives with actionable insights to optimize their engagements, increase prescription uptake (Rx), and enhance overall brand performance. It showcased how Astellas and Axtria worked together to leverage data, convert it into useful rep suggestions, and ultimately improve brand performance through better field execution.
More on illi News
- A discussion with Bayer on "Utilizing AI to Identify Unrealized Opportunities and Optimize End-to-End Field Force Operations." This session explored Bayer's AI-driven transformation of field force operations across design, planning, execution, and talent management. It showcased the tangible business impact of AI.
- A workshop led by Axtria on "Enabling EDA Automation for Commercial Analytics using LLM." This demonstrated how generative AI can automate exploratory data analysis (EDA) processes, transforming raw data into actionable insights. Additionally, Axtria also conducted a focus session on "Accelerating Pharma Business Analytics with AI-Ready Data Products Strategy," where they shared how AI-ready data products can streamline data management, unify fragmented data landscapes, and accelerate analytics while reducing operational costs.
Axtria's participation in the PMSA 2024 Fall Symposium highlighted their commitment to driving innovation in the pharmaceutical industry through the use of AI. Their thought leadership presentations and collaborations with client partners showcased their expertise in harnessing the power of AI to improve decision-making and enhance overall business performance.
During the conference, Axtria received several awards for its thought leadership presentations and participated as a gold sponsor, reaffirming its commitment to exchanging knowledge and enhancing the impact of AI in the pharmaceutical industry.
Sudip Chakraborty, Principal and Head of AI/GenAI at Axtria, stated that "At Axtria, we believe that AI is not just a tool but a transformative force that can reshape the pharmaceutical landscape." He also emphasized their dedication to partnering with industry leaders to harness AI-driven insights and solutions that improve decision-making, optimize field operations, and ultimately enhance patient outcomes.
More on illi News
- Chicago: ICYMI: Mayor Brandon Johnson's ICE Playbook Spreads as Cities Challenge Trump's Crackdown
- On the 296th Anniversary of the Ceremony That Made His Ancestor Emperor, a Cherokee Descendant Publishes the Novel That Restores Him
- Mayor Brandon Johnson, DFSS, My Chi. My Future., Host Fifth Annual Teen Bash at Navy Pier, Empowering Young Chicagoans
- The City of Naperville Launches 2026 National Community Survey
- NRx Pharmaceuticals Could Be on the Verge of a Breakout Year as AI, FDA Catalysts, and Mental Health Demand Converge
Axtria's experts collaborated with client partners to lead insightful presentations and discussions on advanced AI-driven solutions and strategies tailored for the pharmaceutical industry. Some of these sessions included:
- A case study presented by Axtria and Gilead Sciences on "Nuances of Leveraging Generative AI for Structured Data Processing and Insights." This highlighted the importance of empowering non-technical users to access insights through natural language generation-based applications. These GenAI-powered tools provide intuitive user interfaces with robust data access controls, enabling broader access to critical insights.
- A collaboration between Axtria and Astellas Pharma on "AI-Enabled Action Alerts to Enhance Field Effectiveness." This session demonstrated how AI-powered recommendations are transforming field operations by providing representatives with actionable insights to optimize their engagements, increase prescription uptake (Rx), and enhance overall brand performance. It showcased how Astellas and Axtria worked together to leverage data, convert it into useful rep suggestions, and ultimately improve brand performance through better field execution.
More on illi News
- DC Accounting Firm Offers Free Business CRM to Small Business Clients Alongside Weekly Bookkeeping Model
- CCHR: Psychiatric Drugs Fuel Rising Death Toll: National Adverse Drug Event Awareness Day Confronts America's Medication Crisis
- Explosive $10 Billion Counter-Drone Market with AI-Powered Defense Ecosystem: ZenaTech, Inc. (N A S D A Q: ZENA)
- High-Value Execution Phase Begins: Bitcoin Bancorp Ignites Texas Rollout of Digital Asset ATM Network: Bitcoin Bancorp (Stock Symbol: BCBC) $BCBC
- Upgrade Kitchen Performance with SMEG Parts at HnK Parts for Ovens & Fridges
- A discussion with Bayer on "Utilizing AI to Identify Unrealized Opportunities and Optimize End-to-End Field Force Operations." This session explored Bayer's AI-driven transformation of field force operations across design, planning, execution, and talent management. It showcased the tangible business impact of AI.
- A workshop led by Axtria on "Enabling EDA Automation for Commercial Analytics using LLM." This demonstrated how generative AI can automate exploratory data analysis (EDA) processes, transforming raw data into actionable insights. Additionally, Axtria also conducted a focus session on "Accelerating Pharma Business Analytics with AI-Ready Data Products Strategy," where they shared how AI-ready data products can streamline data management, unify fragmented data landscapes, and accelerate analytics while reducing operational costs.
Axtria's participation in the PMSA 2024 Fall Symposium highlighted their commitment to driving innovation in the pharmaceutical industry through the use of AI. Their thought leadership presentations and collaborations with client partners showcased their expertise in harnessing the power of AI to improve decision-making and enhance overall business performance.
Filed Under: Business
0 Comments
Latest on illi News
- Chicago: Mayor Brandon Johnson and BACP Announce Selected Organizations for the Neighborhood Retail Activation Program
- TicTac Group acquires French EdTech company Distrisoft
- Suburban Orthopaedics Expands Comprehensive Orthopaedic Care in Northwest Suburbs
- Chicago: Mayor Brandon Johnson Joins Goodman Theatre To Celebrate Opening of Theater of The Mind
- Chicago: Mayor Brandon Johnson Statement on Preliminary Ruling Restoring Red Line Extension Funding
- Kettera Strategies Selects Bite Stream
- Mark Dobosz Makes Donorassess.org Free To Every Nonprofit On The Planet
- Genpak Announces Closure of Utah Manufacturing Facility
- Vanguard Gifted Academy Students Join Millions Globally for World Maths Day 2026
- Newborn Care Network Introduces Clinical Standard to Bridge the Six-Week Postpartum Gap
- The AAA Metamorphosis: How Global Gaming Is Redefining Production Standards
- Monexplora Explains the Options Mechanics Behind March's Tech Selloff and VIX Surge
- Ill House District 83, Candidate, Loyola Grad Calls for Corrective Action Due to Gorman Murder
- Larry R. Wasion Highlights Jump Gate I: Time Chair. The Opening Novel in His Expansive Science Fiction Series
- Mayor Brandon Johnson Launches Repair Chicago Engagement Series and Survey to Inform City's Reparations Study
- New Book Reveals The Science Of Predictions
- Compliance Alert: Maryland, Texas Regulate Use of Artificial Intelligence in Utilization Reviews
- Elite Benefits Launches "Benefits Survival Guide" to Help Employers Control Costs and Uncertainty
- Colony Ridge Communities Celebrates Successful Soccer Season Kickoff with Families and Youth
- Pregis Launches Sharp™ Lynx 18 Automated Bagger: Unlocking Packing Efficiency in Space-Constrained Fulfillment Operations